Research with us before you invest
The vaccines allowed Covid to be treated as an aberration, but we must not forget what it really was: A preview of the kind of planetary challenges that await us. In December 2019, as the world was looking ahead to a new year, a novel virus was quietly spreading in China, having most likely made…
Read More “World at risk of repeating past mistakes: Covid-19 lessons ignored” »
China is witnessing a surge in respiratory illnesses, including HMPV, influenza, and Covid-19, predominantly affecting children and the elderly, as healthcare systems face mounting pressure. Five years after the onset of the Covid-19 pandemic, China is grappling with an outbreak of the human metapneumovirus (HMPV). Reports and social media posts suggest that the virus is…
Read More “HMPV another Covid-19-type scare in China? As of now, what we know – Report” »
Clinical trial : During pandemic, process was faster and nods for Covid-19 trials came in 30 days Industry insiders feel that approval timelines for clinical trials in India have slipped back to the pre-pandemic days. During the pandemic, trial approval timelines had significantly improved by 30-40 per cent, claim industry insiders. Speaking to Business Standard, Sanjay…
Read More “Clinical trial approval timelines prior to Covid19- Report” »
